Table 1.
Demographic and baseline data for dialysis cohort (n = 92)
| Variable | Values | |
|---|---|---|
| Age, mean±SD | 56.1±14.8 | |
| Female gender, n (%) | 37 (40.2) | |
| Race, n (%) | ||
| White | 39 (42.9) | |
| African American | 42 (46.1) | |
| Others | 10 (10.9) | |
| Cause of ESRD, n (%) | ||
| Diabetes mellitus | 37 (40.2) | |
| Glomerulonephritis | 14 (15.2) | |
| Hypertension | 18 (19.6) | |
| Others | 13 (14.1) | |
| Comorbidities, n (%) | ||
| Hypertension | 84 (91.3) | |
| Diabetes | 49 (53.3) | |
| Stroke | 10 (10.9) | |
| Coronary artery disease | 15 (16.3) | |
| Congestive heart failure | 28 (30.4) | |
| Liver cirrhosis | 4 (4.4) | |
| Peripheral vascular disease | 8 (8.7) | |
| Depression | 10 (10.9) | |
| Dementia or mild cognitive impairment | 7 (7.6) | |
| Dialysis modality, n (%) | ||
| In-center/conventional hemodialysis | 71 (77.2) | |
| Home hemodialysis | 7 (7.6) | |
| Peritoneal dialysis | 14 (15.2) | |
| Laboratory (mean±SD) | ||
| Hemoglobin, g/dL | 11.0±1.5 | |
| Albumin, g/dL | 3.8±0.5 | |
| Kt/V | 1.7±0.4 | |
| Proportion meeting laboratory target, n (%) | ||
| Hemoglobin ≥ 10 g/dL | 72 (78.2) | |
| Albumin ≥ 4.0 g/dL | 36 (39.1) | |
| Kt/V goal | 68 (73.9) | |
ESRD, end-stage renal disease; g/dL, grams per deciliter.